

I-Mab Biopharma: Detailed Company Information & Corporate Profile
Summary
I-Mab Biopharma is a public company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Chairman & CEO is occupied by Jingwu Zhang Zang. Its headquarters is located at Pudong, Shanghai Municipality, CN. The number of employees ranges from 100 to 250. The annual revenue of I-Mab Biopharma varies between 100M and 500M. Total funding of the company - $976.1M. To connect with I-Mab Biopharma employee register on SignalHire.
| I-Mab Biopharma Website | i-mabbiopharma.com |
| Social Links | |
| Phone Number | 86-21-6057-8000 |
| Industries | |
| I-Mab Biopharma Headquarters address | 2440 Research Blvd, Rockville, Maryland, 20850 US |
| Employees Size | 10-50 employees |
| Specialties | Biopharmaceutical, Antibody, Immuno-oncology , Biologics, Drug Development , Cancer, Bispecific antibodies, Monoclonal antibodies |
| SIC Code | 8000 |
| Founded | 2016 |
| Estimated Annual Revenue | $100M - 500M |
| Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2017 | Privately Held | 25 - 100 | < 1M | $8M | |
| 2014 | Public Company | 1.0K - 5.0K | 80.4M | $1.2B | |
| 2017 | Privately Held | 25 - 100 | 2.5M | $210.5M | |
| 2012 | - | - | $- |
Workforce Turnover
Corporate Tenure Analytics
I-Mab Biopharma Workforce Experience Insights
12% for 1–2 years12% for 3–4 years47% for 5–7 years29% for 8–10 yearsCompanies Similar to I-Mab Biopharma
I-Mab Biopharma Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.








